Journal Information

Statistics

Follow this link to access the full text of the article

Tropical/Infectoparasitary Dermatology
Lobomycosis: exuberant presentation with malignant transformation
Wanessa da Costa Lima
Corresponding author
wanessa.costa.lima@hotmail.com

Corresponding author.
, Sidharta Quercia Gadelha, Mara Lúcia Gomes de Souza, Virginia Vilasboas Figueiras
Fundação de Dermatologia Tropical Heitor Vieira Dourado, Manaus, AM, Brazil
Read
4067
Times
was read the article
1896
Total PDF
2171
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 99 90 189
2024 March 105 69 174
2024 February 115 74 189
2024 January 95 54 149
2023 December 68 95 163
2023 November 81 87 168
2023 October 59 75 134
2023 September 74 83 157
2023 August 55 33 88
2023 July 82 35 117
2023 June 76 48 124
2023 May 56 19 75
2023 April 33 18 51
2023 March 68 49 117
2023 February 44 44 88
2023 January 38 38 76
2022 December 60 44 104
2022 November 81 50 131
2022 October 74 62 136
2022 September 50 71 121
2022 August 48 50 98
2022 July 43 58 101
2022 June 57 51 108
2022 May 41 59 100
2022 April 55 51 106
2022 March 52 70 122
2022 February 49 40 89
2022 January 92 104 196
2021 December 137 91 228
2021 November 127 96 223
2021 October 42 79 121
2021 September 15 9 24
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.